Literature DB >> 21751119

Suitable device for thoracoscopic talc poudrage in malignant pleural effusion.

Andrea Billè1, Piero Borasio, Mara Gisabella, Luca Errico, Robert Gatherer, Francesco Ardissone.   

Abstract

Chemical pleurodesis is widely used in symptomatic patients with malignant pleural effusion to relieve symptoms, prevent fluid recurrence, and improve quality of life. Talc has been repeatedly found to be the most effective sclerosant agent, and thoracoscopic talc poudrage has been found to be the most effective pleurodesis technique. A homogeneous talc distribution on the visceral and parietal pleura helps to achieve complete pleural symphysis. We have recently adopted a new suitable sterile device that delivers talc under low and constant pressure, facilitating uniform coating of the whole pleural surface and avoiding inappropriate deposition of talc clumps.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21751119     DOI: 10.1007/s11748-010-0746-0

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  8 in total

Review 1.  The evidence on the effectiveness of management for malignant pleural effusion: a systematic review.

Authors:  Carol Tan; Artyom Sedrakyan; John Browne; Simon Swift; Tom Treasure
Journal:  Eur J Cardiothorac Surg       Date:  2006-04-12       Impact factor: 4.191

2.  Simple technique of talc delivery for video-assisted talc pleurodesis.

Authors:  Rajwinder S Jutley; Salman Waqar; Neil Raha; Paul Fenton; Pradip K Sarkar
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-02-12

3.  Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions.

Authors:  G Cardillo; F Facciolo; L Carbone; M Regal; F Corzani; A Ricci; M Di Martino; M Martelli
Journal:  Eur J Cardiothorac Surg       Date:  2002-02       Impact factor: 4.191

4.  Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases.

Authors:  J R Viallat; F Rey; P Astoul; C Boutin
Journal:  Chest       Date:  1996-12       Impact factor: 9.410

Review 5.  Pleurodesis for malignant pleural effusions.

Authors:  P Shaw; R Agarwal
Journal:  Cochrane Database Syst Rev       Date:  2004

6.  Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.

Authors:  Julius P Janssen; Gareth Collier; Phillippe Astoul; Gian Franco Tassi; Marc Noppen; Francisco Rodriguez-Panadero; Robert Loddenkemper; Felix Jf Herth; Stefano Gasparini; Charles H Marquette; Birgit Becke; Marios E Froudarakis; Peter Driesen; Chris T Bolliger; Jean-Marie Tschopp
Journal:  Lancet       Date:  2007-05-05       Impact factor: 79.321

7.  Early and late mortality after pleurodesis for malignant pleural effusion.

Authors:  Alain Bernard; Régis Bernard de Dompsure; Olivier Hagry; Jean Pierre Favre
Journal:  Ann Thorac Surg       Date:  2002-07       Impact factor: 4.330

8.  Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses.

Authors:  Volker Steger; Ute Mika; Heikki Toomes; Tobias Walker; Corinna Engel; Thomas Kyriss; Gerhard Ziemer; Godehard Friedel
Journal:  Ann Thorac Surg       Date:  2007-06       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.